These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23339067)

  • 1. Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents.
    Hatting M; Zhao G; Schumacher F; Sellge G; Al Masaoudi M; Gaβler N; Boekschoten M; Müller M; Liedtke C; Cubero FJ; Trautwein C
    Hepatology; 2013 Jun; 57(6):2189-201. PubMed ID: 23339067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
    Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
    J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.
    Thapaliya S; Wree A; Povero D; Inzaugarat ME; Berk M; Dixon L; Papouchado BG; Feldstein AE
    Dig Dis Sci; 2014 Jun; 59(6):1197-206. PubMed ID: 24795036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of apoptosis and the related genes in non-alcoholic steatohepatitis].
    Nan YM; Wu WJ; Yao XX; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):41-6. PubMed ID: 17244458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
    Greene MW; Burrington CM; Lynch DT; Davenport SK; Johnson AK; Horsman MJ; Chowdhry S; Zhang J; Sparks JD; Tirrell PC
    PLoS One; 2014; 9(1):e85848. PubMed ID: 24454937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.
    Chaudhary K; Liedtke C; Wertenbruch S; Trautwein C; Streetz KL
    J Hepatol; 2013 Dec; 59(6):1292-8. PubMed ID: 23928400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
    Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
    Imarisio C; Alchera E; Sutti S; Valente G; Boccafoschi F; Albano E; Carini R
    Clin Sci (Lond); 2012 Sep; 123(5):323-32. PubMed ID: 22439844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.
    Hao F; Cubero FJ; Ramadori P; Liao L; Haas U; Lambertz D; Sonntag R; Bangen JM; Gassler N; Hoss M; Streetz KL; Reissing J; Zimmermann HW; Trautwein C; Liedtke C; Nevzorova YA
    Cell Death Dis; 2017 Oct; 8(10):e3152. PubMed ID: 29072704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis.
    Liu R; Pan X; Whitington PF
    Liver Int; 2009 Mar; 29(3):337-43. PubMed ID: 18710424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
    Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A; Leclercq IA; Williams J; Farrell GC
    J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.